Related Tags >> AstraZeneca Biotech IPO Phase II GlaxoSmithKline

targacept News

Most Popular targacept Story

GSK inks $1.5B dollar pain deal with Targacept

July 27, 2007 — 6:59am ET

GSK and Targacept have inked a discovery, development and commercialization deal for therapeutics that target specified neuronal nicotinic receptors. Targecept will gain $35 million up front and up... Read more...

targacept Press Releases

AstraZeneca PLC (AZN) and Targacept, Inc. (TRGT) Announce Top-Line Results from Phase IIb Study of AZD3480 in Alzheimer's Diseas
PRESS RELEASE: Targacept Announces Results of Phase II Study of TC-2696 in Postoperative Dental Pain
PRESS RELEASE: Targacept Announces Plans to Develop Enantiomer of Mecamylamine as Augmentation Therapy for Depression

Latest Headlines

Targacept launches Phase II; Amylin touts blood sugar data; drug reduces craving for alcohol
June 10, 2008
ALSO NOTED: Agennix OK'd to launch late-stage lung cancer trial; QLT reorganizes; Ventana still resisting Roche bid; and much m
January 17, 2008
Targacept shares tank on mid-stage pain failure
December 3, 2007
Targacept pushes depression therapy into the clinic
October 23, 2007
DEALS: GSK, Targacept ink $1.5B pain deal
August 2, 2007
GSK inks $1.5B dollar pain deal with Targacept
July 27, 2007
ALSO NOTED: Quest Diagnostics buys HemoCue; Affymax pockets $10M milestone;Pozen to file response on Trexima; and much more...
January 31, 2007
Editor's Corner
January 1, 2007
Press Release: Targacept to Receive $20M Milestone Payment as AstraZeneca Plans to Continue Development of AZD3480
December 28, 2006
Press Release: Targacept Announces Positive Results of Phase II Clinical Trial in Major Depression
November 9, 2006
ALSO NOTED: MedImmune sells CytoGam; Targacept reports mixed data; and much more...
November 8, 2006
CAT fetches $1.3B in AstraZeneca buyout
May 14, 2006
SPOTLIGHT: OMRIX raises IPO haul to $35M
May 7, 2006
Targacept raises IPO cash, Vanda cuts prices
April 11, 2006
ALSO NOTED: Chiron pulls MMR vaccine off the market; Targacept sets IPO price; and much more...
March 15, 2006
Targacept takes second shot at $60M IPO
January 16, 2006
DEALS: AstraZeneca, AtheroGenics ink $1B licensing deal
January 4, 2006

Paid Research Reports